Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy?
Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy? — المؤلف: Cuneo, Antonio — Mediterranean journal of hematology and infectious diseases 2019
- المؤلف
- Cuneo, Antonio
- النشر
- Mediterranean journal of hematology and infectious diseases 2019
- الوصف
- e2019024 p.